Skip to main content
main-content

Diabetes complications & comorbidities


Browse the latest news, expert commentary, and educational content on diabetes complications and comorbidities.


05-07-2021 | Glucagon | News

Dasiglucagon promising for severe hypoglycemia in children with type 1 diabetes

Dasiglucagon, a next-generation glucagon analog in a ready-to-use formulation, rapidly restores plasma glucose levels following severe hypoglycemia in children and adolescents with type 1 diabetes, show findings from a phase 3 trial.

05-05-2021 | Dapagliflozin | News

Dapagliflozin gains FDA approval for CKD indication

Click through to read more on this announcement

05-04-2021 | Medications | News

Objective assessment of medication taking advised to reduce type 2 diabetes complications

Suboptimal medication-taking identified through urine testing is associated with a higher prevalence of microvascular and macrovascular complications in people with type 2 diabetes than found with consistent usage, report researchers.

04-28-2021 | DUKPC 2021 | Conference coverage | News

Blood pressure, lipids may contribute to long-term dementia risk in type 2 diabetes

The onset of dementia in people with type 2 diabetes may be foreshadowed by elevated levels of some vascular risk factors 1 to 2 decades beforehand, say researchers.

04-27-2021 | Mental health | News

Dementia added to list of early-onset diabetes dangers

Research published in JAMA suggests the risk for dementia increases with younger age at type 2 diabetes diagnosis, with the risk further increased in people who have a stroke.

04-15-2021 | Hyperglycemia | News

Hyperglycemia aversiveness linked to increased hypoglycemia exposure

People with type 1 diabetes who are “hyperglycemia aversive” reduce their hyperglycemia exposure at the cost of increased hypoglycemia and, potentially, reduced hypoglycemia awareness, research suggests.

04-14-2021 | COVID-19 | News

Psychologic wellbeing may influence type 2 diabetes glucose control during COVID-19 lockdown

COVID-19 restrictions do not significantly impact glycated hemoglobin levels in individuals with type 2 diabetes, but those with poor psychologic wellbeing may experience worsening glycemic control, suggest findings from an Italian study.

04-06-2021 | Adolescents | News

Fear more than reality of hypoglycemia impacts QoL in adolescents

Fear of hypoglycemia, rather than the actual frequency of hypoglycemic events, may impact diabetes-specific quality of life in adolescents, say researchers.

03-31-2021 | Older adults | News

Glargine-300 might be preferable for older people with type 2 diabetes

Analysis of older participants in the BRIGHT trial suggests that this subgroup may do slightly better with insulin glargine-300 than with degludec.

03-30-2021 | SGLT2 inhibitors | News

Treatment with SGLT2 inhibitors may reduce risk for kidney stones

SGLT2 inhibitor treatment could lower the risk for incident and recurrent kidney stones in people with type 2 diabetes, suggest Danish study results.

03-26-2021 | Cardiovascular disorders | News

Higher cardiorenal disease burden in type 1 vs type 2 diabetes

Adults with type 1 diabetes have a greater burden of cardiovascular and renal disease than those with type 2 diabetes, researchers report.

03-25-2021 | Ketoacidosis | News

Mortality twice as likely with early DKA readmission

Readmission to hospital within a month of admission for diabetic ketoacidosis is common and associated with an increased mortality risk, say researchers.

03-24-2021 | Basal insulin Fc | News

Second weekly insulin shows phase 2 promise for type 2 diabetes

A novel weekly insulin achieves similar glycemic control to insulin degludec at a higher fasting glucose target, report the investigators at the virtual ENDO 2021 meeting.

03-22-2021 | Hypoglycemia | News

Hypoglycemia treatment advice needs modifying for low-glucose suspend systems

The amount of carbohydrate needed to treat mild or moderate hypoglycemia in people with type 1 diabetes using a predictive low-glucose suspend system may be considerably lower than what is currently recommended, report researchers.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits